Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV
Provided By GlobeNewswire
Last update: May 2, 2025
VAMOS analysis highlights link between EVAF and reduced muscle quality
Case series reports success with combination tesamorelin/GLP-1 receptor agonist therapy
Read more at globenewswire.comNASDAQ:THTX (9/5/2025, 8:00:01 PM)
3.27
+0.02 (+0.62%)
Find more stocks in the Stock Screener
